Measurement company Agilent Technologies has announced the opening of its new Spectroscopy Technology Innovation Centre in Mulgrave, Victoria. The $25 million centre houses cutting-edge research and testing laboratories, as well as user demo and training facilities. [ + ]

The Coalition has formally released its agricultural policy, which promises to allocate $100 million to research and development in the sector. [ + ]

Pharmaxis (ASX:PXS) will cut back on resources dedicated to a launch of CF treatment Bronchitol in France, due to delays reaching agreement with the CEPS on reimbursement. [ + ]

Nanosonics (ASX:NAN) director Michael Kavanagh will take over as CEO from October, with current chief Ron Weinberger moving into a new role. [ + ]

A higher R&D tax benefit in FY13 helped Calzada (ASX:CZD) narrow its loss for the FY13 financial year to $1.5m. [ + ]

Genetic Technologies (ASX:GTG) has arranged to place an extra $800k in shares to sophisticated investors, and to increase the underwriting for its planned SPP to $1.8m. [ + ]

Three early-career scientists have been awarded $25,000 one-year fellowships. [ + ]

Nanosonics has tapped senior Cochlear executive Michael Kavanagh to become its next CEO. Kavanagh will take the roles of CEO and president effective 21 October. [ + ]

A collaboration of University of Auckland departments has been recognised for its contribution to reducing and refining the way animals are used for scientific research. [ + ]

The 2013 Curtin Commercial Innovation Awards winners have been announced, with the three winning entries each having strong or potential applications in the medical industry. [ + ]

AusBiotech has welcomed 'The Coalition’s Policy to Boost the Competitiveness of Australian Manufacturing' with its support for a "new approach" to manufacturing and a returned focus to Australian industry and SMEs. [ + ]

Professor Mary Garson, from the University of Queensland’s (UQ) School of Chemistry and Molecular Biosciences, has become the first Australian to receive a 'Distinguished Woman in Chemistry or Chemical Engineering' award. [ + ]

BioDiem (ASX:BDM) will be granted a US divisional patent covering the use of BDM-I in skin and wound infections caused by different fungi and bacteria. [ + ]

Commercialisation Australia will award Nexvet a further $1.5m in grant funding to help the company bring its PETisation technology to market. [ + ]

Australia's Chief Scientist, Professor Ian Chubb, this week honoured the 2013 recipients of the Science and Industry Endowment Fund (SIEF) grants to science and scientists. [ + ]